---
input_text: Biochemical correlates of neuropsychiatric illness in maple syrup urine
  disease. Maple syrup urine disease (MSUD) is an inherited disorder of branched chain
  amino acid metabolism presenting with neonatal encephalopathy, episodic metabolic
  decompensation, and chronic amino acid imbalances. Dietary management enables survival
  and reduces risk of acute crises. Liver transplantation has emerged as an effective
  way to eliminate acute decompensation risk. Psychiatric illness is a reported MSUD
  complication, but has not been well characterized and remains poorly understood.
  We report the prevalence and characteristics of neuropsychiatric problems among
  37 classical MSUD patients (ages 5-35 years, 26 on dietary therapy, 11 after liver
  transplantation) and explore their underlying mechanisms. Compared with 26 age-matched
  controls, MSUD patients were at higher risk for disorders of cognition, attention,
  and mood. Using quantitative proton magnetic resonance spectroscopy, we found lower
  brain glutamate, N-acetylaspartate (NAA), and creatine concentrations in MSUD patients,
  which correlated with specific neuropsychiatric outcomes. Asymptomatic neonatal
  course and stringent longitudinal biochemical control proved fundamental to optimizing
  long-term mental health. Neuropsychiatric morbidity and neurochemistry were similar
  among transplanted and nontransplanted MSUD patients. In conclusion, amino acid
  dysregulation results in aberrant neural networks with neurochemical deficiencies
  that persist after transplant and correlate with neuropsychiatric morbidities. These
  findings may provide insight into general mechanisms of psychiatric illness.
raw_completion_output: |-
  primary_disease: Maple syrup urine disease (MSUD)

  medical_actions: Dietary management; Liver transplantation

  symptoms: Neonatal encephalopathy; Episodic metabolic decompensation; Chronic amino acid imbalances; Disorders of cognition; Attention disorders; Mood disorders

  chemicals: Glutamate; N-acetylaspartate (NAA); Creatine

  action_annotation_relationships: Dietary management TREATS neonatal encephalopathy IN MSUD; Dietary management PREVENTS episodic metabolic decompensation IN MSUD; Liver transplantation TREATS episodic metabolic decompensation IN MSUD; Liver transplantation PREVENTS acute crises IN MSUD
prompt: |+
  Split the following piece of text into fields in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Liver transplantation PREVENTS acute crises IN MSUD

  ===

extracted_object:
  primary_disease: MONDO:0009563
  medical_actions:
    - Dietary management
    - MAXO:0001175
  symptoms:
    - Neonatal encephalopathy
    - Episodic metabolic decompensation
    - Chronic amino acid imbalances
    - Disorders of cognition
    - Attention disorders
    - Mood disorders
  chemicals:
    - CHEBI:29987
    - CHEBI:21547
    - CHEBI:16919
  action_annotation_relationships:
    - subject: Dietary management
      predicate: TREATS
      object: neonatal encephalopathy
      qualifier: MONDO:0009563
    - subject: Dietary management
      predicate: PREVENTS
      object: episodic metabolic decompensation
      qualifier: MONDO:0009563
      subject_extension: Dietary management
    - subject: MAXO:0001175
      predicate: TREATS
      object: episodic metabolic decompensation
      qualifier: MONDO:0009563
    - subject: MAXO:0001175
      predicate: PREVENTS
      object: acute crises
      qualifier: MONDO:0009563
named_entities:
  - id: MONDO:0009563
    label: Maple syrup urine disease (MSUD)
  - id: CHEBI:25017
    label: Leucine
  - id: CHEBI:22359
    label: alloisoleucine (allo-ile)
  - id: HP:0100626
    label: End stage liver diseases
  - id: MONDO:0100193
    label: End stage liver diseases
  - id: MONDO:0019052
    label: Inborn errors of metabolism
  - id: MAXO:0000603
    label: Peritoneal dialysis
  - id: MAXO:0001175
    label: Liver transplantation (LT)
  - id: MAXO:0009003
    label: Preimplantation genetic testing (PGT)
  - id: CHEBI:24898
    label: isoleucine
  - id: CHEBI:27266
    label: valine
  - id: MAXO:0000088
    label: diet
  - id: HP:0001263
    label: mental and motor retardation
  - id: HP:0002098
    label: respiratory distress
  - id: MONDO:0008143
    label: Organic Acidemias (OAs)
  - id: MONDO:0000688
    label: Organic Acidemias
  - id: MONDO:0021055
    label: Familial amyloidotic polyneuropathy (FAP)
  - id: HP:0003159
    label: hyperoxaluria
  - id: MONDO:0002474
    label: primary hyperoxaluria
  - id: MONDO:0008294
    label: acute intermittent porphyria
  - id: HP:0011034
    label: Amyloidosis
  - id: HP:0011968
    label: Poor feeding
  - id: HP:0001259
    label: Coma
  - id: HP:0001252
    label: Hypotonia
  - id: HP:0002013
    label: vomiting
  - id: HP:0000737
    label: irritability
  - id: HP:0003256
    label: Coagulopathy
  - id: HP:0001993
    label: Ketoacidosis
  - id: HP:0001251
    label: Ataxia
  - id: MONDO:0017052
    label: intermediate maple syrup urine disease (iMSUD)
  - id: MAXO:0001525
    label: Intravenous administration
  - id: CHEBI:17895
    label: Tyr
  - id: CHEBI:16828
    label: Trp
  - id: CHEBI:141437
    label: His
  - id: CHEBI:16044
    label: Met
  - id: CHEBI:16857
    label: Thr
  - id: CHEBI:30011
    label: Gln
  - id: CHEBI:17295
    label: Phe
  - id: CHEBI:28300
    label: glutamine
  - id: CHEBI:16449
    label: alanine
  - id: CHEBI:27363
    label: zinc
  - id: CHEBI:27568
    label: selenium
  - id: CHEBI:27432
    label: alpha-linolenic acid (18:3n-3)
  - id: CHEBI:36005
    label: docosahexaenoic acid (22:6n-3)
  - id: CHEBI:17865
    label: Alpha-ketoisocaproate (KIC)
  - id: HP:0003811
    label: Neonatal death
  - id: HP:0001873
    label: thrombocytopenia
  - id: HP:0002615
    label: hypotension
  - id: HP:0002901
    label: hypocalcemia
  - id: HP:0001942
    label: metabolic acidosis
  - id: CHEBI:145810
    label: Insulin
  - id: MONDO:0008867
    label: biliary atresia
  - id: CHEBI:48430
    label: Alpha-ketoisocaproic acid (KIC)
  - id: MAXO:0000600
    label: renal replacement therapy (RRT)
  - id: MAXO:0000601
    label: dialysis
  - id: CHEBI:15603
    label: amino-acid mixture without leucine (Leu), valine, isoleucine
  - id: MAXO:0001495
    label: parenteral administration
  - id: MAXO:0000943
    label: Dried blood spot (DBS) monitoring
  - id: CHEBI:22918
    label: Branched-chain amino acids (BCAA)
  - id: CHEBI:33349
    label: <Dried blood spot (DBS)>
  - id: MONDO:0009949
    label: PC deficiency
  - id: HP:0001977
    label: abnormal blood clotting
  - id: HP:0000717
    label: Autism
  - id: HP:0001249
    label: Intellectual disability
  - id: HP:0001250
    label: Seizures
  - id: MONDO:0004739
    label: <Urea cycle defects (UCD), organic acidemias (OA), maple syrup urine disease
      (MSUD)>
  - id: HP:0001987
    label: elevated ammonia levels
  - id: CHEBI:29987
    label: Glutamate
  - id: CHEBI:21547
    label: N-acetylaspartate (NAA)
  - id: CHEBI:16919
    label: Creatine
